3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
9
Melanoma
4
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Transplant-Related Hematologic Malignancy
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Interventions
Cytarabine
4
Azacitidine
4
venetoclax
3
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Injections
3
Biopsy
3
pegylated granulocyte colony-stimulating factor
2
Tacrolimus
2
Mitoxantrone
2
Gemtuzumab
2
Decitabine
2
Daunorubicin
2
Cyclophosphamide
2
Cladribine
2
Busulfan
2
Bone Marrow Transplantation
2
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
fedratinib
1
enasidenib
1
aldesleukin
1
Thiotepa
1
Spinal Puncture
1
Specimen Handling
1
Social Determinants of Health
1
Sirolimus
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Mycophenolic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Monocytic, Acute
×
sargramostim
×
1 year
×
Clear all
No trials found.